ProfoundBio has raised over $55 million co-led by Lilly Asia Ventures (LAV) and LYFE Capital, while Xiaobing AI has secured funding from IDG, and GGV, others.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
